Skip over main navigation
  • Log in
  • Basket: (0 items)
Hepatitis Australia
Listen
  • Search
  • Instagram
  • Twitter
  • Facebook
  • YouTube
National Hepatitis Infoline
Menu
  • About us
    • Who we are
    • Our Team
    • Our Board
    • Our Members
    • Corporate documents
    • Our website
    • Contact Us
    • Support Hepatitis Australia
  • Hepatitis information
    • Liver Health
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
    • Lived Experience Stories
    • Other Languages
  • How to get help
    • National Hepatitis Infoline
    • Your Rights and Responsibilities
    • For friends and family
    • Local hepatitis organisations
    • COVID-19
  • Our work
    • World Hepatitis Day
    • Australia's Biggest Quiz
    • Ending Hepatitis C Campaign
    • Hepatitis B Health + Law research partnership
    • National Hep C 50,000 Project
    • Parliamentary Event: We can eliminate hepatitis B!
    • Policy and Advocacy
    • Past campaigns
  • Workforce
    • Resources
    • Training Opportunities
  • News
    • Latest News
    • Media Releases
  • Admin
    • Log in
  • Basket: (0 items)

Hepatitis B Health + Law research partnership

The University of Technology Sydney Faculty of Law has been awarded $2.2 million from the Australian Government’s Blood Borne Viruses (BBV) and Sexually Transmissible Infections (STI) Research Program, to establish a new research partnership to identify and eliminate legal barriers to testing and treatment for people living with HIV and/or Hepatitis B.

The Health+Law research partnership will be led by Chief Investigator Dr David Carter, a UTS Law academic with expertise in health law.

Health+Law will include a consortium of health, community and legal sector bodies: the HIV/AIDS Legal Centre, the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), the National Association of People with HIV Australia (NAPWHA) and Hepatitis Australia.

Dr Carter said the partnership will also draw on the expertise of HIV- and hepatitis- related community organisations from across Australia, and people with lived experience of blood-borne viruses. Dr David Carter from UTS Law will lead the project.

“It’s an absolute privilege to be working with such an exceptional consortium of organisations and researchers across Australia on this project,” said Dr Carter.

Hepatitis Australia CEO, Carrie Fowlie, said the project will generate high quality, community-owned and -driven data on people’s legal needs and the experiences they face.

“This information will present an alternative to some of the narrower monitoring and surveillance data, which does not always offer a full picture of people’s lives and the diversity of their needs,” Ms Fowlie said.

Project, policy and law reform solicitor, Rhys Evans, from the HIV/AIDS Legal Centre, said national strategies for blood-borne viruses and STIs have consistently recognised the need to eliminate the negative impacts of legal issues on people’s health.

“We are excited to see a project that will directly address these goals and create an enabling legal environment, improving access to justice and health outcomes for our clients,” Mr Evans said.

Alexis Apostolellis, CEO of ASHM, said clinicians who support people living with blood-borne viruses know that a range of things happening in a person’s life can affect health outcomes, and that includes legal needs.

“Healthcare workers and legal services both play a vital role in supporting the health and wellbeing of people living with blood-borne viruses, and this project will help build stronger connections between the two,” he said.

Co-Chief Investigator, Dr Anthea Vogl, from UTS Law said the project aims to break new ground in understanding the effects of migration status and Medicare ineligibility on health, testing and treatment.

“These are urgent questions, and critical to our understanding of the relationship between legal needs and health,” Dr Vogl said.

Health+Law will have four principal activities, to be delivered over four consecutive years – 2022‑2026:

  1. National assessment of enabling legal environment and barriers to testing and treatment: a national survey of people living with HIV or Hepatitis B; in-depth interviews with culturally diverse and Medicare-ineligible priority groups; and technical legal analysis, to create Australia’s first evidence-base of legal barriers and enablers to better health outcomes.
  2. Understanding the different impacts of legal barriers: an analysis of relative impacts on testing and treatment, quality of life, and health service delivery, to understand priorities for legal support and services, and law and policy reform.
  3. Development of STI- and Blood-Borne Virus-specific legal needs screening and referral tool and education: the co-design and validation by clinicians, people with lived experience, peers and other key stakeholders of a screening tool and online education support, to help triage legal needs and determine most suitable legal support and services.
  4. Establishment of national network of specialist STI and Blood-Borne Virus-responsive legal services providers: the setting up of standards, accreditation, and continuing legal education, to increase nation-wide capability for identifying and eliminating legal barriers to testing and treatment.
     

Professor Anita Stuhmcke, Dean of the Faculty of Law at UTS, said that the faculty is well known for research that generates positive impacts for the communities in which we live and work.

“The bringing together of our partners in the health, community and legal sectors will see the Faculty of Law continue to achieve great impact, improving access to justice, the rule of law and the health of our community.”  

Published: 17th October, 2022

Updated: 21st October, 2022

Author: Danny Adams

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Michael Daly: Policy Analyst

  • Kelly Berghella: Campaign Manager

  • Jessica Abbey: Campaign Manager

  • Statement: You can breastfeed safely with hepatitis B or hepatitis C

    Statement: You can breastfeed safely with hepatitis B or hepatitis C

    There is a common misconception that people living with hepatitis B and/or hepatitis C cannot safely breastfeed. Recent misleading media coverage has suggested that drinking breast milk can easily pass on hepatitis B and hepatitis C. This is not the case.

Related

  • Australia's Biggest Quiz

    Australia's Biggest Quiz

    Register now to attend a local community event or join online

  • National Hep C 50,000 Project

    National Hep C 50,000 Project

    The 50,000 Project is an innovative national partnership project to scale up testing and treatment to find 50,000 people living with hepatitis C by the end of 2022. In doing so, the 50,000 Project will be central in Australia achieving the 2022 national hepatitis C targets for testing and treatment.

  • National Hepatitis Infoline

    National Hepatitis Infoline

    The National Hepatitis Infoline provides confidential and free information on hepatitis B and hepatitis C.

Most read

  • No, you’re not being tested for hepatitis as part of a routine blood test

    No, you’re not being tested for hepatitis as part of a routine blood test

    Hepatitis B and C are the most common blood borne viruses in Australia but testing for them is not part of normal blood tests—you generally have to ask your doctor.

  • A cure for hepatitis C

    A cure for hepatitis C

    You can take medicine to cure your hepatitis C. The tablets are easy to take and work very well. Most people don't have any side-effects.

  • Living with hepatitis B: The myth of the healthy carrier

    Living with hepatitis B: The myth of the healthy carrier

    If you’ve been told that you are “just a healthy carrier”, read on for a myth-busting update from Dr Alice Lam.

  • What is hepatitis C?

    What is hepatitis C?

    Basic information about hepatitis C and how it can affect you.

  • Hepatitis B medicine

    Hepatitis B medicine

    Medicines for hepatitis B help you live well with the virus. Talk to your doctor about whether starting treatment is right for you.

  • Testing for hepatitis B

    Testing for hepatitis B

    Tests used to diagnose hepatitis B

  • Testing for hepatitis C

    Testing for hepatitis C

    Information about the tests used to diagnose hepatitis C (hep C) infection

  • Hepatitis B vaccination

    Hepatitis B vaccination

    Hepatitis B can be prevented with a safe and effective vaccine.

  • What is hepatitis B?

    What is hepatitis B?

    Basic information about hepatitis B transmission and how it affects people.

  • Hepatitis C symptoms

    Hepatitis C symptoms

    Symptoms of hepatitis C are not always obvious

Info

Hepatitis Australia is a registered charity. 
ABN: 38 442 686 487

© Copyright 2019 Hepatitis Australia.
All rights reserved.
View our copyright statement here

Helpful links

  • Contact us
  • Full sitemap
  • Accessibillity
  • Terms & conditions
  • Privacy policy
  • Login
  • Logout
  • Manager

Member sites

  • Australian Capital Territory
  • New South Wales
  • Northern Territory
  • South Australia
  • Victoria
  • Queensland
  • Western Australia
  • Tasmania 

Hepatitis Australia acknowledges the Traditional Owners and Custodians of the land, waters and community where we walk, live and work. We value Aboriginal and Torres Strait Islander cultures, traditions, views and ways of life and pay our respects to Elders past and present.

Information provided on this website is for general information only and not intended as medical advice. Hepatitis Australia encourages all readers to seek independent medical advice before making any decisions based on the information provided on this website.

Hepatitis Australia is a partner organisation of healthdirect Australia.


Images used on this site may include stock photos and the associated messaging may not represent the personal situation, views or beliefs of the people in the images.